ArticleRegenerative therapy2020

Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy.

Lei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.